The 158th Session of the WHO Executive Board (EB) was held from February 2 – 7, 2026 in Geneva, Switzerland.
What is the aim of the WHO EB?
The annual Board meeting is held in January when the members agree upon the agenda for the World Health Assembly and the resolutions to be considered by the Health Assembly. A second shorter meeting takes place in May-June, as a follow-up to the Health Assembly. The main functions of the Board are to implement the decisions and policies of the Health Assembly, and advise and generally to facilitate its work.
This January, the EB focused on several key global health priorities. These include advancing universal health coverage, addressing health emergencies and improving global well-being.As a non-state actor (NSA) in official relations with WHO, SIOP participated in the official proceedings, connected with the global cancer and rare disease community, led one constituency statement, an individual statement and supported others.Those interested in viewing the EB158 proceedings are invited to access the recording via the EB158 landing page, which includes links to the recording and important EB documents, such as agenda and daily schedules.

As usual, the EB158 agenda is very comprehensive and we attempted to match them with the priorities outlined in our strategic plan. Hence, SIOP was actively engaged on the following topic:

AGENDA ITEM 6: Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases: SIOP led constituency statement supported by:

  • List of Non-State Actors participating in the Statement
    • International Society of Paediatric Oncology (SIOP) – organizer
    • Childhood Cancer International (CCI)
    • European Association for Injury Prevention and Safety Promotion (EuroSafe)
    • International Agency for the Prevention of Blindness (IAPB)
    • International Association for Dental Research (IADR)
    • International Association for Hospice and Palliative Care (IAHPC)
    • International Council of Nurses (ICN)
    • International Pediatric Association (IPA)
    • International Psycho-Oncology Society (IPOS)
    • International Society of Radiology (ISR)
    • World Federation of Nuclear Medicine and Biology (WFNMB)
    • World Federation of Societies of Anesthesiologists (WFSA)

“Building on momentum for childhood NCDs: From global commitments to implementation towards enhanced survival, quality of life, safety, and equity”

Read statement

Statements have been posted to official WHO NSA statement platform as well as on the SIOP website. We would like to thank Mrs Olga Kozhaeva (Director European and Global Health Policy, Paediatric Oncology, Siop Europe) for her unwavering guidance, our Advocacy committeeWHO NSA engagement committee and all partners who contributed their expertise to these statements.

Watch our constituency statement on AGENDA ITEM 6: Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases here.
Speaker: Prof Maja Beck-Popovic (Chair, WHO NSA Engagement Committee)

We would like to thank Prof Maja Beck-Popovic, WHO NSA Engagement Committee Chair, to make the time in her busy schedule to attend the official proceedings and be our voice.

SIOP is now a step further in placing the fight against Childhood and Adolescent Cancer on the Global Agenda and making a difference in the lives of children with cancer and their families worldwide.

The SIOP Global Advocacy Committee thanks the SIOP community and all partners for their continuous support during the application process.

We look forward to using this opportunity to expand our work together to improve the global situation for children with cancer.